azilsartan + chlortalidone Tablets, immediate release (IR) 40 mg + 12.5 mg, 40 mg + 25 mg
Dossier type
CTD
Dossier status
Under development
Country of origin
South Korea
GMP approvals
PICS
Manufacturer #7563
A pharmaceutical manufacturer engaged in research-driven development and supply of pharmaceutical products, with a focus on therapies for the central nervous system as well as cardiovascular and gastrointestinal disorders. The company emphasises differentiated R&D capability including open-innovation and incremental drug development, and supports globalization through export and partnership.
None